Psychiatric Services
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Psychiatr Serv 59:526-529, May 2008
doi: 10.1176/appi.ps.59.5.526
© 2008 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
Google Scholar
* Articles by Covell, N. H.
* Articles by Essock, S. M.
PubMed
* PubMed Citation
* Articles by Covell, N. H.
* Articles by Essock, S. M.
Related Collections
* Outcome and Process Assessment
* Quality of Care, Practice Guidelines
* Schizophrenia Spectrum Disorders
* Atypical Neuroleptics
* Conventional Neuroleptics
*Related Articles

Special Section on Implications of CATIE

Implications of CATIE for Mental Health Services Researchers

Nancy H. Covell, Ph.D., Molly T. Finnerty, M.D. and Susan M. Essock, Ph.D.

The authors discuss the implications of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for mental health services researchers, in particular the need to monitor and change prescriber behavior to encourage informed medication selection. Given the complexity and variability of response to antipsychotic medications in CATIE, use of restricted formularies is not the answer. Rather, services researchers should collaborate with service systems to develop interventions to identify questionable prescriber practices and develop interventions to change them. The CATIE results also suggest that some quality measures for antipsychotic treatment, such as the proportion of a population taking second-generation antipsychotics, need to be revisited by researchers. Also, because the CATIE findings highlighted the prevalence of cardiac and metabolic disorders among treatment populations and the potential impact of antipsychotics on these conditions, services researchers should use secondary data to monitor whether prescribers are providing appropriate screening and treatment. Given the health risks of some antipsychotics, services researchers should develop ways to identify individuals at risk, encourage behavior change among prescribers, and support informed and shared decision making about medications. Mental health services researchers can build relationships with multiple stakeholders, including service system administrators, service providers, and consumers, to help translate results from trials such as CATIE into policy and practice.


Related Articles:

May 2008: This Month's Highlights
Psychiatr Serv 2008 59: 475. [Full Text] [PDF]

Introduction to the CATIE Special Section
Marvin S. Swartz
Psychiatr Serv 2008 59: 497-499. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Psychiatr. Serv.Home page
M. S. Swartz
Introduction to the CATIE Special Section
Psychiatr Serv, May 1, 2008; 59(5): 497 - 499.
[Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2008 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org